Table 5. Analyses of factors affecting recurrence in non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
| Risk factor | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| OR (95% CI) | P | aOR (95% CI) | P | ||
| 1-y recurrence | |||||
| Shorter treatment duration (9–11 months) | 1.401 (0.595–3.301) | 0.440 | 1.190 (0.484–2.929) | 0.705 | |
| Age ≥60 years | 2.430 (1.023–5.770) | 0.044 | 2.565 (1.020–6.450) | 0.045 | |
| Previous history of NTM treatment | 3.058 (0.876–10.676) | 0.080 | 2.769 (0.735–10.438) | 0.132 | |
| Diabetes mellitus | 2.934 (0.950–9.060) | 0.061 | 1.960 (0.586–6.560) | 0.275 | |
| Surgical resection | 6.630 (0.896–49.050) | 0.064 | 8.100 (0.976–67.194) | 0.053 | |
| 3-y recurrence | |||||
| Shorter treatment duration (9–11 months) | 1.244 (0.611–2.531) | 0.548 | 1.047 (0.487–2.250) | 0.907 | |
| Age ≥60 years | 2.932 (1.503–5.718) | 0.002 | 2.511 (1.256–5.019) | 0.009 | |
| Previous history of NTM treatment | 12.727 (1.526–106.135) | 0.019 | 8.598 (0.997–74.189) | 0.051 | |
| Number of involved lobes | 1.299 (1.006–1.677) | 0.045 | 1.207 (0.919–1.586) | 0.176 | |
OR, odds ratio; CI, confidence interval; aOR, adjusted OR; NTM, nontuberculous mycobacteria lung disease.